• Clinical Trials

    Beyond evidence-based, Mobio’s patient-facing mobile health platform and psychotherapeutic interventions are clinically validated through numerous rigorous trials completed, underway, and launching all over the world. 

    broken image

    Clinical trial locations.

    broken image

  •  Mobile Health Platform Validation

    Mobio’s highly customisable and functional patient-facing mobile health platform is a versatile medical tool, clinically validated in adults and adolescents for various patient populations and use-cases. 

    Precision Psychiatry

     

    Population health management

     

    Immediate care for waitlisted patients

     

    Remote monitoring

     

    Symptom Severity Triage

  • Publication List

    Mobio is committed to publishing as much clinical research and technology development in the peer-reveiwed literature as feasible, simultaneously protecting our freedom to operate and tradesecrets.

    The SEAMLESS Study: Development, feasibility and pilot efficacy outcomes of a SmartphonE App-based MindfuLnEss intervention for cancer SurvivorS.

    Subnis et al. (2025). In Prep.

    Mindfulness-Based Intervention for Mild Traumatic Brain Injury (MBI-4-mTBI): a pilot and feasibility randomized control trial.

    Ledoux et al. (2025). In Prep.

    Working Smarter, Not Harder: The effects of a digital therapeutic on exercise performance in an activated RCT.

    Rai et al. (2024) Mindfulness (Submitted)

    Context-Dependency in Medicine: How Neuronal Excitability Influences the Impact of Dopamine on Cognition.

    Amandi et al. (2024) Neural Regeneration Research. 10.4103/NRR.NRR-D-24-00704

    Acceptability, engagement, outcomes, and dose-response associations of a mindfulness-based meditation app in individuals waiting for psychological services.

    Daros et al. (2024) BMC Digital Health (PrePrint)

    An exploratory randomized controlled trial of virtual reality as a non-pharmacological adjunctive intervention for adults with chronic cancer-related pain

    Garett et al. (2024) BMC Digital Health Vol 2, Article 28. 

    Scalable precision psychiatry with an objective measure of psychological stress: Prospective real world study.

    Wang et al. (2024) Journal of Medical Internet Research.

    Acceptability, usability, and credibility of a mindfulness-based digital therapeutic for pediatric concussion: A mixed-method study.

    Sicard et al., (2024) Digital Health. 10.

    Smartphone-App delivered Mindfulness-Based Intervention for Mild Traumatic Brain Injury (MBI-4-mTBI): A Feasibility Randomized Control Trial in Adolescents.

    Ledoux et al. (2024) JMIR Research Protocols. 13:e57226.

    Development of Therapeutic Alliance and Social Presence in a Digital Intervention for Pediatric Concussion: Qualitative Exploratory Study.

    Kane et al. (2024) JMIR Formative Research. 8(e49133), 1.

    A Dual Effect of Dopamine on Hippocampal LTP and Cognitive Functions in Control and Kindled Mice. The Journal of Neuroscience.

    Ahmadi et al. (2024) Journal of Neuroscience. 44(5):e0926212023.

    Effects of a Mindfulness App for Outpatients Waitlisted for Psychological Interventions.

    Patel et al. (2023) Society for Digital Mental Health Conference.

    Improved health-related quality of life (HR-QOL) with use of an online mindfulness tool in patients with metastatic renal cell carcinoma (mRCC) receiving immunotherapy (IO).

    Bergerot et al. (2023) American Society of Clinical Oncology, 41(6_suppl), 660.

    Growing pains: Lessons learned from a failed mobile mindfulness clinical trial for patients with complex care needs.

    Hood et al. (2022) Contemporary Clinical Trials Communications, 26.

    Whole-brain opto-fMRI map of mouse VTA dopaminergic activation reflects structural projections with small but significant deviations.

    Ioanas et al. (2022) Translational Psychiatry, 12(60).

    Psycho-Oncology and the Relevance of a Biopsychosocial Screening Program.

    Bergerot et al. (2022) Oncology, 36(9), 552-556. 

    Prospective assessment of a smartphone-app based mindfulness program for patients with metastatic renal cell carcinoma (mRCC).

    Bergerot et al. (2022) Journal of Clinical Oncology, 40(6_suppl), 324.

    AI-Enabled Remote and Objective Quantification of Stress at Scale.

    Al-Jebrni et al. (2020) Biomedical Signal Processing and Control, 59.

    Patients perceptions of virtual reality therapy in the management of chronic cancer pain.

    Garrett et al. (2020) Heliyon, 6(5).

    A Smartphone App–Based Mindfulness Intervention for Cancer Survivors: Protocol for a Randomized Controlled Trial.

    Subnis et al. (2020) JMIR Research Protocols, 9.

    Effects of a Mindfulness-Meditation App on Subjective Well-Being: An Active Randomized Controlled Trial and Experience Sampling Study.

    Walsh et al. (2019) JMIR Mental Health, 6(1).

    A brain-wide functional map of the serotonergic responses to acute stress and fluoxetine.

    Grandjean et al. (2019) Nature Communications, 10.

    Big Data Analytics and AI in Mental Healthcare.

    Rosenfeld et al. (2019) Applications of big data in healthcare. ArXiv, 1903.

    A Bayesian Multi-Scale Framework for Photoplethysmogram Imaging Waveform Processing. 

    Chwyl et al. (2016) Journal of Computational Vision and Imaging Systems, 2(1)

    Time-Frequency Domain Analysis via Pulselets for Non-Contact Heart Rate Estimation from Remotely Acquired Photoplethysmograms.

    Chwyl et al. (2016) Computer and Robot Vision, 13th Edition, 201-207.

    SAPPHIRE: Stochastically Acquired Photoplethysmogram for Heart Rate Inference in Realistic Environments.

    Chwyl et al. (2016) IEEE International Conference on Image Processing (ICIP), 1230-1234.

  • Indications

    Mobio's technologies are being used to provide clinical solutions for a healthy and growing number of medical indications. Increasingly, we are working with academic and commercial partners to develop interventions for these and other indications. Contact us for collaboration.

    broken image

  • Clinical Partners

    Mobio is fortunate to have partnered with acclaimed research institutions from around the world. We are endlessly grateful to the nearly 200 clinicians and researchers that have played a role in R&D efforts with Mobio.

  •  

    Funding Sources

    Mobio has secured, along with its partners above, over $6 million USD in non-dilutive funding to support dozens of clinical trials. We are grateful to the following institutions for the generous contributions.

  • Certifications

    Mobio Interactive’s digital therapeutic platform “AmDTx” is CE MDD Class I, DCB0129, and ISO 27001 certified; GDPR-, HIPAA- and PHIPA-compliant; and undergoing certification for CE MDR Class IIa, ISO 13485, ISO 9000, and ISO 82304-2.

    Mobio Interactive's digital theragnostic platform leverages computer vision and AI to objectively quantify mental wellbeing for each individual patient in real time.

    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More